Filter programs:

18 Programs

  • Second Opinion

    Clinical Investigators Provide Perspectives on the Future Role of AKT Inhibition in the Management of Prostate Cancer

    Explore program
  • Second Opinion

    Integrating Novel Approaches into the Management of Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer

    Explore program
  • Cancer Conference Update

    ESMO Congress 2025 Review — Prostate Cancer

    Explore program
  • Cancer Conference Update

    ESMO Congress 2025 — Urothelial Bladder Cancer and Prostate Cancer

    Explore program